Updated Findings of the Association and Functional Studies of DRD2/ANKK1 Variants with Addictions

Molecular Neurobiology

Volumn 51, Issue 1, 2015, Pages 281-299

  Ma, Yunlong ^a   Yuan, Wenji ^a   Jiang, Xianzhong ^a   Cui, Wen Yan ^a   Li, Ming D ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Alcoholism; ANKK1; DRD2; Functional variants; Nicotine dependence

Indexed keywords

ANKK1 PROTEIN, HUMAN; DOPAMINE 2 RECEPTOR; DRD2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE;

ADDICTION; ALCOHOLISM; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; SINGLE NUCLEOTIDE POLYMORPHISM; TOBACCO DEPENDENCE;

ALCOHOLISM; BEHAVIOR, ADDICTIVE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, DOPAMINE D2; TOBACCO USE DISORDER;

EID: 84939881435     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-014-8826-2     Document Type: Article

References (214)

1. WHO (2008) Report on the Global Tobacco Epidemic, 2008: the MPOWER package. World Health Organization, Geneva
2. Sullivan PF, Kendler KS (1999) The genetic epidemiology of smoking. Nicotine Tob Res Off J Soc Res Nicotine Tob 1(Suppl 2):S51–S57, discussion S69-70
3. Hamilton AS, Lessov-Schlaggar CN, Cockburn MG, Unger JB, Cozen W, Mack TM (2006) Gender differences in determinants of smoking initiation and persistence in California twins. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 15(6):1189–1197. doi:10.1158/1055-9965.EPI-05-0675
4. Hardie TL, Moss HB, Lynch KG (2006) Genetic correlations between smoking initiation and smoking behaviors in a twin sample. Addict Behav 31(11):2030–2037. doi:10.1016/j.addbeh.2006.02.010
5. True WR, Heath AC, Scherrer JF, Waterman B, Goldberg J, Lin N, Eisen SA, Lyons MJ, Tsuang MT (1997) Genetic and environmental contributions to smoking. Addiction 92(10):1277–1287
6. Li MD, Cheng R, Ma JZ, Swan GE (2003) A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 98(1):23–31
7. Li MD (2003) The genetics of smoking related behavior: a brief review. Am J Med Sci 326(4):168–173
8. Hamilton AS, Lessov-Schlaggar CN, Cockburn MG, Unger JB, Cozen W, Mack TM (2006) Gender differences in determinants of smoking initiation and persistence in California twins. Cancer Epidemiol Biomarkers Prev 15(6):1189–1197
9. McGue M (1999) The behavioral genetics of alcoholism. Curr Dir Psychol Sci 8:109–115
10. Heath AC, Bucholz KK, Madden PA, Dinwiddie SH, Slutske WS, Bierut LJ, Statham DJ, Dunne MP, Whitfield JB, Martin NG (1997) Genetic and environmental contributions to alcohol dependence risk in a national twin sample: consistency of findings in women and men. Psychol Med 27(6):1381–1396
11. Edenberg HJ, Foroud T (2006) The genetics of alcoholism: identifying specific genes through family studies. Addict Biol 11(3–4):386–396. doi:10.1111/j.1369-1600.2006.00035.x
12. Ho MK, Goldman D, Heinz A, Kaprio J, Kreek MJ, Li MD, Munafo MR, Tyndale RF (2010) Breaking barriers in the genomics and pharmacogenetics of drug addiction. Clin Pharmacol Ther 88(6):779–791. doi:10.1038/clpt.2010.175
13. Swan GE, Hudmon KS, Jack LM, Hemberger K, Carmelli D, Khroyan TV, Ring HZ, Hops H, Andrews JA, Tildesley E, McBride D, Benowitz N, Webster C, Wilhelmsen KC, Feiler HS, Koenig B, Caron L, Illes J, Cheng LS (2003) Environmental and genetic determinants of tobacco use: methodology for a multidisciplinary, longitudinal family-based investigation. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 12(10):994–1005
14. Little HJ (2000) Behavioral mechanisms underlying the link between smoking and drinking. Alcohol Res Health J Natl InstAlcohol Abuse Alcohol 24(4):215–224
15. Di Chiara G, Bassareo V, Fenu S, De Luca MA, Spina L, Cadoni C, Acquas E, Carboni E, Valentini V, Lecca D (2004) Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47(Suppl 1):227–241. doi:10.1016/j.neuropharm.2004.06.032
16. Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347(6289):146–151. doi:10.1038/347146a0
17. Van Tol HH, Bunzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB, Civelli O (1991) Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350(6319):610–614. doi:10.1038/350610a0
18. Sunahara RK, Guan HC, O'Dowd BF, Seeman P, Laurier LG, Ng G, George SR, Torchia J, Van Tol HH, Niznik HB (1991) Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature 350(6319):614–619. doi:10.1038/350614a0
19. Tiberi M, Jarvie KR, Silvia C, Falardeau P, Gingrich JA, Godinot N, Bertrand L, Yang-Feng TL, Fremeau RT Jr, Caron MG (1991) Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor. Proc Natl Acad Sci U S A 88(17):7491–7495
20. Zhang Y, Bertolino A, Fazio L, Blasi G, Rampino A, Romano R, Lee ML, Xiao T, Papp A, Wang D, Sadee W (2007) Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci U S A 104(51):20552–20557. doi:10.1073/pnas.0707106104
21. Usiello A, Baik JH, Rouge-Pont F, Picetti R, Dierich A, LeMeur M, Piazza PV, Borrelli E (2000) Distinct functions of the two isoforms of dopamine D2 receptors. Nature 408(6809):199–203. doi:10.1038/35041572
22. Rouge-Pont F, Usiello A, Benoit-Marand M, Gonon F, Piazza PV, Borrelli E (2002) Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors. J Neurosci Off J Soc Neurosci 22(8):3293–3301
23. Neville MJ, Johnstone EC, Walton RT (2004) Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 23(6):540–545. doi:10.1002/humu.20039
24. Gelernter J, Panhuysen C, Weiss R, Brady K, Poling J, Krauthammer M, Farrer L, Kranzler HR (2007) Genomewide linkage scan for nicotine dependence: identification of a chromosome 5 risk locus. Biol Psychiatry 61(1):119–126. doi:10.1016/j.biopsych.2006.08.023
25. Yang BZ, Kranzler HR, Zhao H, Gruen JR, Luo X, Gelernter J (2007) Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples. Hum Mol Genet 16(23):2844–2853. doi:10.1093/hmg/ddm240
26. Morley KI, Medland SE, Ferreira MA, Lynskey MT, Montgomery GW, Heath AC, Madden PA, Martin NG (2006) A possible smoking susceptibility locus on chromosome 11p12: evidence from sex-limitation linkage analyses in a sample of Australian twin families. Behav Genet 36(1):87–99. doi:10.1007/s10519-005-9004-0
27. Gelernter J, Yu Y, Weiss R, Brady K, Panhuysen C, Yang BZ, Kranzler HR, Farrer L (2006) Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. Hum Mol Genet 15(24):3498–3507. doi:10.1093/hmg/ddl426
28. Dick DM, Wang JC, Plunkett J, Aliev F, Hinrichs A, Bertelsen S, Budde JP, Goldstein EL, Kaplan D, Edenberg HJ, Nurnberger J Jr, Hesselbrock V, Schuckit M, Kuperman S, Tischfield J, Porjesz B, Begleiter H, Bierut LJ, Goate A (2007) Family-based association analyses of alcohol dependence phenotypes across DRD2 and neighboring gene ANKK1. Alcohol Clin Exp Res 31(10):1645–1653. doi:10.1111/j.1530-0277.2007.00470.x
29. Nelson EC, Lynskey MT, Heath AC, Wray N, Agrawal A, Shand FL, Henders AK, Wallace L, Todorov AA, Schrage AJ, Saccone NL, Madden PA, Degenhardt L, Martin NG, Montgomery GW (2013) ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: importance of considering drug exposure. JAMA Psychiatry 70(3):325–333. doi:10.1001/jamapsychiatry.2013.282
30. Li MD, Burmeister M (2009) New insights into the genetics of addiction. Nat Rev Genet 10(4):225–231. doi:10.1038/nrg2536
31. Li MD, Ma JZ, Cheng R, Dupont RT, Williams NJ, Crews KM, Payne TJ, Elston RC (2003) A genome-wide scan to identify loci for smoking rate in the Framingham Heart Study population. BMC Genet 4(Suppl 1):S103
32. Bierut LJ, Rice JP, Goate A, Hinrichs AL, Saccone NL, Foroud T, Edenberg HJ, Cloninger CR, Begleiter H, Conneally PM, Crowe RR, Hesselbrock V, Li T-K, Nurngerger JI, Porjesz B, Schuckit MA, Reich T (2004) A genomic scan for habitual smoking in families of alcoholics: common and specific genetic factors in substance dependence. Am J Med Genet 124:19–27
33. Lander E, Kruglyak L (1995) Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11(3):241–247. doi:10.1038/ng1195-241
34. Huang W, Payne TJ, Ma JZ, Beuten J, Dupont RT, Inohara N, Li MD (2009) Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 34(2):319–330. doi:10.1038/npp.2008.37
35. Wei J, Chu C, Wang Y, Yang Y, Wang Q, Li T, Zhang L, Ma X (2012) Association study of 45 candidate genes in nicotine dependence in Han Chinese. Addict Behav 37(5):622–626. doi:10.1016/j.addbeh.2012.01.009
36. Yan J, Aliev F, Webb BT, Kendler KS, Williamson VS, Edenberg HJ, Agrawal A, Kos MZ, Almasy L, Nurnberger JI Jr, Schuckit MA, Kramer JR, Rice JP, Kuperman S, Goate AM, Tischfield JA, Porjesz B, Dick DM (2013) Using genetic information from candidate gene and genome-wide association studies in risk prediction for alcohol dependence. Addict Biol. doi:10.1111/adb.12035
37. Xu K, Lichtermann D, Lipsky RH, Franke P, Liu X, Hu Y, Cao L, Schwab SG, Wildenauer DB, Bau CH, Ferro E, Astor W, Finch T, Terry J, Taubman J, Maier W, Goldman D (2004) Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Arch Gen Psychiatry 61(6):597–606. doi:10.1001/archpsyc.61.6.597
38. Konishi T, Calvillo M, Leng AS, Lin KM, Wan YJ (2004) Polymorphisms of the dopamine D2 receptor, serotonin transporter, and GABA(A) receptor beta(3) subunit genes and alcoholism in Mexican-Americans. Alcohol 32(1):45–52. doi:10.1016/j.alcohol.2003.11.002
39. Du Y, Wan YJ (2009) The interaction of reward genes with environmental factors in contribution to alcoholism in Mexican Americans. Alcohol Clin Exp Res 33(12):2103–2112. doi:10.1111/j.1530-0277.2009.01050.x
40. Ishiguro H, Arinami T, Saito T, Akazawa S, Enomoto M, Mitushio H, Fujishiro H, Tada K, Akimoto Y, Mifune H, Shioduka S, Hamaguchi H, Toru M, Shibuya H (1998) Association study between the -141C Ins/Del and TaqI A polymorphisms of the dopamine D2 receptor gene and alcoholism. Alcohol Clin Exp Res 22(4):845–848
41. Prasad P, Ambekar A, Vaswani M (2010) Dopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males: a preliminary study. BMC Med Genet 11:24. doi:10.1186/1471-2350-11-24
42. Li T, Liu X, Zhao J, Hu X, Ball DM, el Loh W, Sham PC, Collier DA (2002) Allelic association analysis of the dopamine D2, D3, 5-HT2A, and GABA(A)gamma2 receptors and serotonin transporter genes with heroin abuse in Chinese subjects. Am J Med Genet 114(3):329–335
43. Al-Eitan LN, Jaradat SA, Hulse GK, Tay GK (2012) Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent. BMC Res Notes 5:497. doi:10.1186/1756-0500-5-497
44. Ducci F, Kaakinen M, Pouta A, Hartikainen AL, Veijola J, Isohanni M, Charoen P, Coin L, Hoggart C, Ekelund J, Peltonen L, Freimer N, Elliott P, Schumann G, Jarvelin MR (2011) TTC12-ANKK1-DRD2 and CHRNA5-CHRNA3-CHRNB4 influence different pathways leading to smoking behavior from adolescence to mid-adulthood. Biol Psychiatry 69(7):650–660. doi:10.1016/j.biopsych.2010.09.055
45. De Ruyck K, Nackaerts K, Beels L, Werbrouck J, De Volder A, Meysman M, Salhi B, Van Meerbeeck J, Thierens H (2010) Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients. Pharmacogenomics 11(8):1053–1063. doi:10.2217/pgs.10.75
46. Spitz MR, Shi H, Yang F, Hudmon KS, Jiang H, Chamberlain RM, Amos CI, Wan Y, Cinciripini P, Hong WK, Wu X (1998) Case–control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst 90(5):358–363
47. Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Ozkaragoz T, Fitch RJ, Wood R, Finley O, Sadlack F (1993) Genetic predisposition in alcoholism: association of the D2 dopamine receptor TaqI B1 RFLP with severe alcoholics. Alcohol 10(1):59–67
48. Vereczkei A, Demetrovics Z, Szekely A, Sarkozy P, Antal P, Szilagyi A, Sasvari-Szekely M, Barta C (2013) Multivariate analysis of dopaminergic gene variants as risk factors of heroin dependence. PLoS One 8(6):e66592. doi:10.1371/journal.pone.0066592
49. Noble EP, Blum K, Khalsa ME, Ritchie T, Montgomery A, Wood RC, Fitch RJ, Ozkaragoz T, Sheridan PJ, Anglin MD et al (1993) Allelic association of the D2 dopamine receptor gene with cocaine dependence. Drug Alcohol Depend 33(3):271–285
50. Persico AM, Bird G, Gabbay FH, Uhl GR (1996) D2 dopamine receptor gene TaqI A1 and B1 restriction fragment length polymorphisms: enhanced frequencies in psychostimulant-preferring polysubstance abusers. Biol Psychiatry 40(8):776–784. doi:10.1016/0006-3223(95)00483-1
51. Moyer RA, Wang D, Papp AC, Smith RM, Duque L, Mash DC, Sadee W (2011) Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 36(4):753–762. doi:10.1038/npp.2010.208
52. Sullivan D, Pinsonneault JK, Papp AC, Zhu H, Lemeshow S, Mash DC, Sadee W (2013) Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interaction. Trans Psychiatry 3:e222. doi:10.1038/tp.2012.146
53. Morton LM, Wang SS, Bergen AW, Chatterjee N, Kvale P, Welch R, Yeager M, Hayes RB, Chanock SJ, Caporaso NE (2006) DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Pharmacogenet Genomics 16(12):901–910. doi:10.1097/01.fpc.0000230417.20468.d0
54. Sasabe T, Furukawa A, Matsusita S, Higuchi S, Ishiura S (2007) Association analysis of the dopamine receptor D2 (DRD2) SNP rs1076560 in alcoholic patients. Neurosci Lett 412(2):139–142. doi:10.1016/j.neulet.2006.10.064
55. Doehring A, Hentig N, Graff J, Salamat S, Schmidt M, Geisslinger G, Harder S, Lotsch J (2009) Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution. Pharmacogenet Genomics 19(6):407–414. doi:10.1097/FPC.0b013e328320a3fd
56. Clarke T-K, Weiss ARD, Ferarro TN, Kampman KM, Dackis CA, Pettinati HM, O'brien CP, Oslin DW, Lohoff FW, Berrettini WH (2013) The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction. Ann Hum Genet. doi:10.1111/ahg.12046
57. Voisey J, Swagell CD, Hughes IP, van Daal A, Noble EP, Lawford BR, Young RM, Morris CP (2012) A DRD2 and ANKK1 haplotype is associated with nicotine dependence. Psychiatry Res 196(2–3):285–289. doi:10.1016/j.psychres.2011.09.024
58. Hill SY, Hoffman EK, Zezza N, Thalamuthu A, Weeks DE, Matthews AG, Mukhopadhyay I (2008) Dopaminergic mutations: within-family association and linkage in multiplex alcohol dependence families. Am J Med Genet B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet 147B(4):517–526. doi:10.1002/ajmg.b.30630
59. Swagell CD, Lawford BR, Hughes IP, Voisey J, Feeney GF, van Daal A, Connor JP, Noble EP, Morris CP, Young RM (2012) DRD2 C957T and TaqIA genotyping reveals gender effects and unique low-risk and high-risk genotypes in alcohol dependence. Alcohol Alcohol 47(4):397–403. doi:10.1093/alcalc/ags047
60. Li MD, Ma JZ, Beuten J (2004) Progress in searching for susceptibility loci and genes for smoking-related behaviour. Clin Genet 66(5):382–392. doi:10.1111/j.1399-0004.2004.00302.x
61. Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Jagadeeswaran P, Nogami H, Briggs AH, Cohn JB (1990) Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA J Am Med Assoc 263(15):2055–2060
62. Amadeo S, Abbar M, Fourcade ML, Waksman G, Leroux MG, Madec A, Selin M, Champiat JC, Brethome A, Leclaire Y et al (1993) D2 dopamine receptor gene and alcoholism. J Psychiatr Res 27(2):173–179
63. Comings DE, Comings BG, Muhleman D, Dietz G, Shahbahrami B, Tast D, Knell E, Kocsis P, Baumgarten R, Kovacs BW et al (1991) The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA J Am Med Assoc 266(13):1793–1800
64. Ovchinnikov IV, Druzina E, Ovtchinnikova O, Zagorovskaya T, Nebarakova T, Anokhina IP (1999) Polymorphism of dopamine D2 and D4 receptor genes and Slavic-surnamed alcoholic patients. Addict Biol 4(4):399–404. doi:10.1080/13556219971380
65. Berggren U, Fahlke C, Aronsson E, Karanti A, Eriksson M, Blennow K, Thelle D, Zetterberg H, Balldin J (2006) The taqI DRD2 A1 allele is associated with alcohol-dependence although its effect size is small. Alcohol Alcohol 41(5):479–485. doi:10.1093/alcalc/agl043
66. Preuss UW, Zill P, Koller G, Bondy B, Sokya M (2007) D2 dopamine receptor gene haplotypes and their influence on alcohol and tobacco consumption magnitude in alcohol-dependent individuals. Alcohol Alcohol 42(3):258–266. doi:10.1093/alcalc/agm030
67. Hou QF, Li SB (2009) Potential association of DRD2 and DAT1 genetic variation with heroin dependence. Neurosci Lett 464(2):127–130. doi:10.1016/j.neulet.2009.08.004
68. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ (1991) Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 48(7):648–654
69. Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK, Morris CM, Perry RH, Ferrier IN, Court JA (1997) D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 7(6):479–484
70. Pohjalainen T, Rinne JO, Nagren K, Lehikoinen P, Anttila K, Syvalahti EK, Hietala J (1998) The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 3(3):256–260
71. Jonsson EG, Nothen MM, Grunhage F, Farde L, Nakashima Y, Propping P, Sedvall GC (1999) Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 4(3):290–296
72. Noble EP (2003) D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet 116B(1):103–125. doi:10.1002/ajmg.b.10005
73. Noble EP, St Jeor ST, Ritchie T, Syndulko K, St Jeor SC, Fitch RJ, Brunner RL, Sparkes RS (1994) D2 dopamine receptor gene and cigarette smoking: a reward gene? Med Hypotheses 42(4):257–260
74. Comings DE, Ferry L, Bradshaw-Robinson S, Burchette R, Chiu C, Muhleman D (1996) The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. Pharmacogenetics 6(1):73–79
75. Wilcox CS, Noble EP, Oskooilar N (2011) ANKK1/DRD2 locus variants are associated with rimonabant efficacy in aiding smoking cessation: pilot data. J Invest Med Off Publ Am Fed Clin Res 59(8):1280–1283. doi:10.231/JIM.0b013e31823581fa
76. Cinciripini P, Wetter D, Tomlinson G, Tsoh J, De Moor C, Cinciripini L, Minna J (2004) The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood. Nicotine Tob Res Off J Soc Res Nicotine Tob 6(2):229–239. doi:10.1080/14622200410001676396
77. Stapleton JA, Sutherland G, O'Gara C, Spirling LI, Ball D (2011) Association between DRD2/ANKK1 Taq1A genotypes, depression and smoking cessation with nicotine replacement therapy. Pharmacogenet Genomics 21(8):447–453. doi:10.1097/FPC.0b013e328347473a
78. Munafo M, Clark T, Johnstone E, Murphy M, Walton R (2004) The genetic basis for smoking behavior: a systematic review and meta-analysis. Nicotine Tob Res Off J Soc Res Nicotine Tob 6(4):583–597. doi:10.1080/14622200410001734030
79. Munafo MR, Timpson NJ, David SP, Ebrahim S, Lawlor DA (2009) Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data. Nicotine Tob Res Off J Soc Res Nicotine Tob 11(1):64–76. doi:10.1093/ntr/ntn012
80. Berlin I, Covey LS, Jiang H, Hamer D (2005) Lack of effect of D2 dopamine receptor TaqI A polymorphism on smoking cessation. Nicotine Tob Res Off J Soc Res Nicotine Tob 7(5):725–728. doi:10.1080/14622200500259176
81. Yoshida K, Hamajima N, Kozaki K, Saito H, Maeno K, Sugiura T, Ookuma K, Takahashi T (2001) Association between the dopamine D2 receptor A2/A2 genotype and smoking behavior in the Japanese. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 10(4):403–405
82. Hamajima N, Ito H, Matsuo K, Saito T, Tajima K, Ando M, Yoshida K, Takahashi T (2002) Association between smoking habits and dopamine receptor D2 taqI A A2 allele in Japanese males: a confirmatory study. J Epidemiol Jpn Epidemiol Assoc 12(4):297–304
83. Zheng C, Shen Y, Xu Q (2012) Rs1076560, a functional variant of the dopamine D2 receptor gene, confers risk of schizophrenia in Han Chinese. Neurosci Lett 518(1):41–44. doi:10.1016/j.neulet.2012.04.052
84. David SP, Mezuk B, Zandi PP, Strong D, Anthony JC, Niaura R, Uhl GR, Eaton WW (2010) Sex differences in TTC12/ANKK1 haplotype associations with daily tobacco smoking in Black and White Americans. Nicotine Tob Res Off J Soc Res Nicotine Tob 12(3):251–262. doi:10.1093/ntr/ntp201
85. Eicher JD, Powers NR, Cho K, Miller LL, Mueller KL, Ring SM, Tomblin JB, Gruen JR (2013) Associations of prenatal nicotine exposure and the dopamine related genes ANKK1 and DRD2 to verbal language. PLoS One 8(5):e63762. doi:10.1371/journal.pone.0063762
86. Wise RA, Rompre PP (1989) Brain dopamine and reward. Annu Rev Psychol 40:191–225. doi:10.1146/annurev.ps.40.020189.001203
87. Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemann R, Ding YS, Pappas N, Shea C, Piscani K (1996) Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res 20(9):1594–1598
88. Tupala E, Hall H, Bergstrom K, Mantere T, Rasanen P, Sarkioja T, Tiihonen J (2003) Dopamine D2 receptors and transporters in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography. Hum Brain Mapp 20(2):91–102. doi:10.1002/hbm.10129
89. Heinz A, Siessmeier T, Wrase J, Hermann D, Klein S, Grusser SM, Flor H, Braus DF, Buchholz HG, Grunder G, Schreckenberger M, Smolka MN, Rosch F, Mann K, Bartenstein P (2004) Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving. Am J Psychiatry 161(10):1783–1789. doi:10.1176/appi.ajp.161.10.1783
90. Thanos PK, Volkow ND, Freimuth P, Umegaki H, Ikari H, Roth G, Ingram DK, Hitzemann R (2001) Overexpression of dopamine D2 receptors reduces alcohol self-administration. J Neurochem 78(5):1094–1103
91. Thanos PK, Taintor NB, Rivera SN, Umegaki H, Ikari H, Roth G, Ingram DK, Hitzemann R, Fowler JS, Gatley SJ, Wang GJ, Volkow ND (2004) DRD2 gene transfer into the nucleus accumbens core of the alcohol preferring and nonpreferring rats attenuates alcohol drinking. Alcohol Clin Exp Res 28(5):720–728
92. Thanos PK, Rivera SN, Weaver K, Grandy DK, Rubinstein M, Umegaki H, Wang GJ, Hitzemann R, Volkow ND (2005) Dopamine D2R DNA transfer in dopamine D2 receptor-deficient mice: effects on ethanol drinking. Life Sci 77(2):130–139. doi:10.1016/j.lfs.2004.10.061
93. Gelernter J, O'Malley S, Risch N, Kranzler HR, Krystal J, Merikangas K, Kennedy JL, Kidd KK (1991) No association between an allele at the D2 dopamine receptor gene (DRD2) and alcoholism. JAMA J Am Med Assoc 266(13):1801–1807
94. Sander T, Ladehoff M, Samochowiec J, Finckh U, Rommelspacher H, Schmidt LG (1999) Lack of an allelic association between polymorphisms of the dopamine D2 receptor gene and alcohol dependence in the German population. Alcohol Clin Exp Res 23(4):578–581
95. Anghelescu I, Germeyer S, Muller MJ, Klawe C, Singer P, Dahmen N, Wetzel H, Himmerich H, Szegedi A (2001) No association between the dopamine d2 receptor taqi a1 allele and earlier age of onset of alcohol dependence according to different specified criteria. Alcohol Clin Exp Res 25(6):805–809
96. Gelernter J, Kranzler H (1999) D2 dopamine receptor gene (DRD2) allele and haplotype frequencies in alcohol dependent and control subjects: no association with phenotype or severity of phenotype. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 20(6):640–649. doi:10.1016/S0893-133X(98)00110-9
97. Chen CH, Chien SH, Hwu HG (1996) Lack of association between TaqI A1 allele of dopamine D2 receptor gene and alcohol-use disorders in atayal natives of Taiwan. Am J Med Genet 67(5):488–490. doi:10.1002/(SICI)1096-8628(19960920)67:5<488::AID-AJMG10>3.0.CO;2-J
98. Lee MS, Lee KJ, Kwak DI (1997) No association between the dopamine D2 receptor gene and Korean alcoholism. Psychiatr Genet 7(2):93–95
99. Lu RB, Ko HC, Chang FM, Castiglione CM, Schoolfield G, Pakstis AJ, Kidd JR, Kidd KK (1996) No association between alcoholism and multiple polymorphisms at the dopamine D2 receptor gene (DRD2) in three distinct Taiwanese populations. Biol Psychiatry 39(6):419–429
100. Munafo MR, Matheson IJ, Flint J (2007) Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case–control studies and evidence of publication bias. Mol Psychiatry 12(5):454–461. doi:10.1038/sj.mp.4001938
101. Smith L, Watson M, Gates S, Ball D, Foxcroft D (2008) Meta-analysis of the association of the Taq1A polymorphism with the risk of alcohol dependency: a HuGE gene-disease association review. Am J Epidemiol 167(2):125–138. doi:10.1093/aje/kwm281
102. Le Foll B, Gallo A, Le Strat Y, Lu L, Gorwood P (2009) Genetics of dopamine receptors and drug addiction: a comprehensive review. Behav Pharmacol 20(1):1–17. doi:10.1097/FBP.0b013e3283242f05
103. Wang F, Simen A, Arias A, Lu QW, Zhang H (2013) A large-scale meta-analysis of the association between the ANKK1/DRD2 Taq1A polymorphism and alcohol dependence. Hum Genet 132(3):347–358. doi:10.1007/s00439-012-1251-6
104. Meyers JL, Nyman E, Loukola A, Rose RJ, Kaprio J, Dick DM (2013) The association between DRD2/ANKK1 and genetically informed measures of alcohol use and problems. Addict Biol 18(3):523–536. doi:10.1111/j.1369-1600.2012.00490.x
105. Connor JP, Young RM, Lawford BR, Ritchie TL, Noble EP (2002) D(2) dopamine receptor (DRD2) polymorphism is associated with severity of alcohol dependence. Eur Psychiatry J Assoc Eur Psychiatrists 17(1):17–23
106. Grant JD, Agrawal A, Bucholz KK, Madden PA, Pergadia ML, Nelson EC, Lynskey MT, Todd RD, Todorov AA, Hansell NK, Whitfield JB, Martin NG, Heath AC (2009) Alcohol consumption indices of genetic risk for alcohol dependence. Biol Psychiatry 66(8):795–800. doi:10.1016/j.biopsych.2009.05.018
107. Kendler KS, Myers J, Dick D, Prescott CA (2010) The relationship between genetic influences on alcohol dependence and on patterns of alcohol consumption. Alcohol Clin Exp Res 34(6):1058–1065. doi:10.1111/j.1530-0277.2010.01181.x
108. Dick DM, Meyers JL, Rose RJ, Kaprio J, Kendler KS (2011) Measures of current alcohol consumption and problems: two independent twin studies suggest a complex genetic architecture. Alcohol Clin Exp Res 35(12):2152–2161. doi:10.1111/j.1530-0277.2011.01564.x
109. Bien TH, Burge R (1990) Smoking and drinking: a review of the literature. Int J Addict 25(12):1429–1454
110. Collins AC (1990) Interactions of ethanol and nicotine at the receptor level. Recent Dev Alcohol Off Publ Am Med Soc Alcohol Res Soc Alcohol Natl Counc Alcohol 8:221–231
111. Zacny JP (1990) Behavioral aspects of alcohol-tobacco interactions. Recent Dev Alcohol Off Publ Am Med Soc Alcohol Res Soc Alcohol Natl Counc Alcohol 8:205–219
112. John U, Meyer C, Rumpf HJ, Hapke U (2003) Probabilities of alcohol high-risk drinking, abuse or dependence estimated on grounds of tobacco smoking and nicotine dependence. Addiction 98(6):805–814
113. Dani JA, Harris RA (2005) Nicotine addiction and comorbidity with alcohol abuse and mental illness. Nat Neurosci 8(11):1465–1470. doi:10.1038/nn1580
114. Darke S, Hall W (1995) Levels and correlates of polydrug use among heroin users and regular amphetamine users. Drug Alcohol Depend 39(3):231–235
115. Dinwiddie SH, Cottler L, Compton W, Abdallah AB (1996) Psychopathology and HIV risk behaviors among injection drug users in and out of treatment. Drug Alcohol Depend 43(1–2):1–11
116. Darke S, Ross J (1997) Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug Alcohol Depend 48(2):135–141
117. Blomqvist O, Ericson M, Engel JA, Soderpalm B (1997) Accumbal dopamine overflow after ethanol: localization of the antagonizing effect of mecamylamine. Eur J Pharmacol 334(2–3):149–156
118. Klee H, Faugier J, Hayes C, Boulton T, Morris J (1990) AIDS-related risk behaviour, polydrug use and temazepam. Br J Addict 85(9):1125–1132
119. Kidorf M, Brooner RK, King VL, Chutuape MA, Stitzer ML (1996) Concurrent validity of cocaine and sedative dependence diagnoses in opioid-dependent outpatients. Drug Alcohol Depend 42(2):117–123
120. True WR, Xian H, Scherrer JF, Madden PA, Bucholz KK, Heath AC, Eisen SA, Lyons MJ, Goldberg J, Tsuang M (1999) Common genetic vulnerability for nicotine and alcohol dependence in men. Arch Gen Psychiatry 56(7):655–661
121. Breslau N (1995) Psychiatric comorbidity of smoking and nicotine dependence. Behav Genet 25(2):95–101
122. Dick DM, Agrawal A, Wang JC, Hinrichs A, Bertelsen S, Bucholz KK, Schuckit M, Kramer J, Nurnberger J Jr, Tischfield J, Edenberg HJ, Goate A, Bierut LJ (2007) Alcohol dependence with comorbid drug dependence: genetic and phenotypic associations suggest a more severe form of the disorder with stronger genetic contribution to risk. Addiction 102(7):1131–1139. doi:10.1111/j.1360-0443.2007.01871.x
123. Agrawal A, Edenberg HJ, Foroud T, Bierut LJ, Dunne G, Hinrichs AL, Nurnberger JI, Crowe R, Kuperman S, Schuckit MA, Begleiter H, Porjesz B, Dick DM (2006) Association of GABRA2 with drug dependence in the collaborative study of the genetics of alcoholism sample. Behav Genet 36(5):640–650. doi:10.1007/s10519-006-9069-4
124. Yang BZ, Kranzler HR, Zhao H, Gruen JR, Luo X, Gelernter J (2008) Haplotypic variants in DRD2, ANKK1, TTC12, and NCAM1 are associated with comorbid alcohol and drug dependence. Alcohol Clin Exp Res 32(12):2117–2127
125. Zai CC, Ehtesham S, Choi E, Nowrouzi B, de Luca V, Stankovich L, Davidge K, Freeman N, King N, Kennedy JL, Beitchman JH (2012) Dopaminergic system genes in childhood aggression: possible role for DRD2. World J Biol Psychiatry Off J World Fed Soc Biol Psychiatry 13(1):65–74. doi:10.3109/15622975.2010.543431
126. Lencz T, Robinson DG, Xu K, Ekholm J, Sevy S, Gunduz-Bruce H, Woerner MG, Kane JM, Goldman D, Malhotra AK (2006) DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients. Am J Psychiatry 163(3):529–531. doi:10.1176/appi.ajp.163.3.529
127. Gong DY, Li ZP, Li B, Gan CB, Wang XJ (2011) Influence of a genetic signature on therapeutic effects of clozapine in schizophrenia subjects from South China. ITME 501–504
128. Ikeda M, Yamanouchi Y, Kinoshita Y, Kitajima T, Yoshimura R, Hashimoto S, O'Donovan MC, Nakamura J, Ozaki N, Iwata N (2008) Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia. Pharmacogenomics 9(10):1437–1443. doi:10.2217/14622416.9.10.1437
129. Mileva-Seitz V, Fleming AS, Meaney MJ, Mastroianni A, Sinnwell JP, Steiner M, Atkinson L, Levitan RD, Matthews SG, Kennedy JL, Sokolowski MB (2012) Dopamine receptors D1 and D2 are related to observed maternal behavior. Genes Brain Behav 11(6):684–694. doi:10.1111/j.1601-183X.2012.00804.x
130. Li T, Liu X, Sham PC, Aitchison KJ, Cai G, Arranz MJ, Deng H, Liu J, Kirov G, Murray RM, Collier DA (1999) Association analysis between dopamine receptor genes and bipolar affective disorder. Psychiatry Res 86(3):193–201
131. Litwin T, Gromadzka G, Samochowiec J, Grzywacz A, Czlonkowski A, Czlonkowska A (2013) Association of dopamine receptor gene polymorphisms with the clinical course of Wilson disease. JIMD Rep 8:73–80. doi:10.1007/8904_2012_163
132. Kishida I, Kawanishi C, Furuno T, Kato D, Ishigami T, Kosaka K (2004) Association in Japanese patients between neuroleptic malignant syndrome and functional polymorphisms of the dopamine D(2) receptor gene. Mol Psychiatry 9(3):293–298. doi:10.1038/sj.mp.4001422
133. Lencz T, Robinson DG, Napolitano B, Sevy S, Kane JM, Goldman D, Malhotra AK (2010) DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia. Pharmacogenet Genomics 20(9):569–572. doi:10.1097/FPC.0b013e32833ca24b
134. Zhang JP, Lencz T, Malhotra AK (2010) D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis. Am J Psychiatry 167(7):763–772. doi:10.1176/appi.ajp.2009.09040598
135. Cordeiro Q, Siqueira-Roberto J, Zung S, Vallada H (2009) Association between the DRD2-141C insertion/deletion polymorphism and schizophrenia. Arq Neuropsiquiatr 67(2A):191–194
136. Arinami T, Gao M, Hamaguchi H, Toru M (1997) A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 6(4):577–582
137. Ohara K, Nagai M, Tani K, Nakamura Y, Ino A, Ohara K (1998) Functional polymorphism of -141C Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia. Psychiatry Res 81(2):117–123
138. Inada T, Arinami T, Yagi G (1999) Association between a polymorphism in the promoter region of the dopamine D2 receptor gene and schizophrenia in Japanese subjects: replication and evaluation for antipsychotic-related features. Int J Neuropsychopharmacol Off Sci J Coll Int Neuropsychopharmacologicum 2(3):181–186. doi:10.1017/S1461145799001492
139. Jonsson EG, Nothen MM, Neidt H, Forslund K, Rylander G, Mattila-Evenden M, Asberg M, Propping P, Sedvall GC (1999) Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia. Schizophr Res 40(1):31–36
140. Breen G, Brown J, Maude S, Fox H, Collier D, Li T, Arranz M, Shaw D, StClair D (1999) 141 C del/ins polymorphism of the dopamine receptor 2 gene is associated with schizophrenia in a British population. Am J Med Genet 88(4):407–410
141. Nemoda Z, Lyons-Ruth K, Szekely A, Bertha E, Faludi G, Sasvari-Szekely M (2010) Association between dopaminergic polymorphisms and borderline personality traits among at-risk young adults and psychiatric inpatients. Behav Brain Funct BBF 6:4. doi:10.1186/1744-9081-6-4
142. Oliveri RL, Annesi G, Zappia M, Civitelli D, De Marco EV, Pasqua AA, Annesi F, Spadafora P, Gambardella A, Nicoletti G, Branca D, Caracciolo M, Aguglia U, Quattrone A (2000) The dopamine D2 receptor gene is a susceptibility locus for Parkinson’s disease. Mov Disord Off J Mov Disord Soc 15(1):127–131
143. Herzberg I, Valencia-Duarte AV, Kay VA, White DJ, Muller H, Rivas IC, Mesa SC, Cuartas M, Garcia J, Bedoya G, Cornejo W, Ruiz-Linares A, Kremeyer B (2010) Association of DRD2 variants and Gilles de la Tourette syndrome in a family-based sample from a South American population isolate. Psychiatr Genet 20(4):179–183. doi:10.1097/YPG.0b013e32833a215a
144. Hwang R, Shinkai T, De Luca V, Muller DJ, Ni X, Macciardi F, Potkin S, Lieberman JA, Meltzer HY, Kennedy JL (2005) Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations. Psychopharmacology 181(1):179–187. doi:10.1007/s00213-005-2223-5
145. Vijayan NN, Bhaskaran S, Koshy LV, Natarajan C, Srinivas L, Nair CM, Allencherry PM, Banerjee M (2007) Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a South Indian population. Behav Brain Funct BBF 3:34. doi:10.1186/1744-9081-3-34
146. Dubertret C, Gorwood P, Gouya L, Deybach JC, Ades J (2001) Association and excess of transmission of a DRD2 haplotype in a sample of French schizophrenic patients. Schizophr Res 49(1–2):203–212
147. Hettinger JA, Liu X, Hudson ML, Lee A, Cohen IL, Michaelis RC, Schwartz CE, Lewis SM, Holden JJ (2012) DRD2 and PPP1R1B (DARPP-32) polymorphisms independently confer increased risk for autism spectrum disorders and additively predict affected status in male-only affected sib-pair families. Behav Brain Funct BBF 8:19. doi:10.1186/1744-9081-8-19
148. Juyal RC, Das M, Punia S, Behari M, Nainwal G, Singh S, Swaminath PV, Govindappa ST, Jayaram S, Muthane UB, Thelma BK (2006) Genetic susceptibility to Parkinson’s disease among South and North Indians: I. Role of polymorphisms in dopamine receptor and transporter genes and association of DRD4 120-bp duplication marker. Neurogenetics 7(4):223–229. doi:10.1007/s10048-006-0048-y
149. Davis C, Levitan RD, Yilmaz Z, Kaplan AS, Carter JC, Kennedy JL (2012) Binge eating disorder and the dopamine D2 receptor: genotypes and sub-phenotypes. Prog Neuro-Psychopharmacol Biol Psychiatry 38(2):328–335. doi:10.1016/j.pnpbp.2012.05.002
150. Chien YL, Hwu HG, Fann CS, Chang CC, Tsuang MT, Liu CM (2013) DRD2 haplotype associated with negative symptoms and sustained attention deficits in Han Chinese with schizophrenia in Taiwan. J Hum Genet 58(4):229–232. doi:10.1038/jhg.2012.157
151. Glatt SJ, Faraone SV, Lasky-Su JA, Kanazawa T, Hwu HG, Tsuang MT (2009) Family-based association testing strongly implicates DRD2 as a risk gene for schizophrenia in Han Chinese from Taiwan. Mol Psychiatry 14(9):885–893. doi:10.1038/mp.2008.30
152. Blasi G, Lo Bianco L, Taurisano P, Gelao B, Romano R, Fazio L, Papazacharias A, Di Giorgio A, Caforio G, Rampino A, Masellis R, Papp A, Ursini G, Sinibaldi L, Popolizio T, Sadee W, Bertolino A (2009) Functional variation of the dopamine D2 receptor gene is associated with emotional control as well as brain activity and connectivity during emotion processing in humans. J Neurosci Off J Soc Neurosci 29(47):14812–14819. doi:10.1523/JNEUROSCI.3609-09.2009
153. Blasi G, Napolitano F, Ursini G, Taurisano P, Romano R, Caforio G, Fazio L, Gelao B, Di Giorgio A, Iacovelli L, Sinibaldi L, Popolizio T, Usiello A, Bertolino A (2011) DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia. Proc Natl Acad Sci U S A 108(3):1158–1163. doi:10.1073/pnas.1013535108
154. Lan J, Song M, Pan C, Zhuang G, Wang Y, Ma W, Chu Q, Lai Q, Xu F, Li Y, Liu L, Wang W (2009) Association between dopaminergic genes (SLC6A3 and DRD2) and stuttering among Han Chinese. J Hum Genet 54(8):457–460. doi:10.1038/jhg.2009.60
155. Frank MJ, Moustafa AA, Haughey HM, Curran T, Hutchison KE (2007) Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning. Proc Natl Acad Sci U S A 104(41):16311–16316. doi:10.1073/pnas.0706111104
156. Frank MJ, Hutchison K (2009) Genetic contributions to avoidance-based decisions: striatal D2 receptor polymorphisms. Neuroscience 164(1):131–140. doi:10.1016/j.neuroscience.2009.04.048
157. Huertas E, Buhler KM, Echeverry-Alzate V, Gimenez T, Lopez-Moreno JA (2012) C957T polymorphism of the dopamine D2 receptor gene is associated with motor learning and heart rate. Genes Brain Behav 11(6):677–683. doi:10.1111/j.1601-183X.2012.00793.x
158. Xu H, Kellendonk CB, Simpson EH, Keilp JG, Bruder GE, Polan HJ, Kandel ER, Gilliam TC (2007) DRD2 C957T polymorphism interacts with the COMT Val158Met polymorphism in human working memory ability. Schizophr Res 90(1–3):104–107. doi:10.1016/j.schres.2006.10.001
159. Doll BB, Hutchison KE, Frank MJ (2011) Dopaminergic genes predict individual differences in susceptibility to confirmation bias. J Neurosci Off J Soc Neurosci 31(16):6188–6198. doi:10.1523/JNEUROSCI.6486-10.2011
160. White MJ, Lawford BR, Morris CP, Young RM (2009) Interaction between DRD2 C957T polymorphism and an acute psychosocial stressor on reward-related behavioral impulsivity. Behav Genet 39(3):285–295. doi:10.1007/s10519-008-9255-7
161. Kawamura Y, Takahashi T, Liu X, Nishida N, Noda Y, Yoshikawa A, Umekage T, Sasaki T (2013) Variation in the DRD2 gene affects impulsivity in intertemporal choice. Open J Psychiatry. doi:10.4236/ojpsych.2013.31005
162. Colzato LS, van den Wildenberg WP, Van der Does AJ, Hommel B (2010) Genetic markers of striatal dopamine predict individual differences in dysfunctional, but not functional impulsivity. Neuroscience 170(3):782–788. doi:10.1016/j.neuroscience.2010.07.050
163. Huertas E, Ponce G, Koeneke MA, Poch C, Espana-Serrano L, Palomo T, Jimenez-Arriero MA, Hoenicka J (2010) The D2 dopamine receptor gene variant C957T affects human fear conditioning and aversive priming. Genes Brain Behav 9(1):103–109. doi:10.1111/j.1601-183X.2009.00543.x
164. Voisey J, Swagell CD, Hughes IP, Morris CP, van Daal A, Noble EP, Kann B, Heslop KA, Young RM, Lawford BR (2009) The DRD2 gene 957C>T polymorphism is associated with posttraumatic stress disorder in war veterans. Depression Anxiety 26(1):28–33. doi:10.1002/da.20517
165. Betcheva ET, Mushiroda T, Takahashi A, Kubo M, Karachanak SK, Zaharieva IT, Vazharova RV, Dimova II, Milanova VK, Tolev T, Kirov G, Owen MJ, O'Donovan MC, Kamatani N, Nakamura Y, Toncheva DI (2009) Case–control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population. J Hum Genet 54(2):98–107. doi:10.1038/jhg.2008.14
166. Fan H, Zhang F, Xu Y, Huang X, Sun G, Song Y, Long H, Liu P (2010) An association study of DRD2 gene polymorphisms with schizophrenia in a Chinese Han population. Neurosci Lett 477(2):53–56. doi:10.1016/j.neulet.2009.11.017
167. Hanninen K, Katila H, Kampman O, Anttila S, Illi A, Rontu R, Mattila KM, Hietala J, Hurme M, Leinonen E, Lehtimaki T (2006) Association between the C957T polymorphism of the dopamine D2 receptor gene and schizophrenia. Neurosci Lett 407(3):195–198. doi:10.1016/j.neulet.2006.08.041
168. Hoenicka J, Aragues M, Rodriguez-Jimenez R, Ponce G, Martinez I, Rubio G, Jimenez-Arriero MA, Palomo T, Psychosis, Addictions Research G (2006) C957T DRD2 polymorphism is associated with schizophrenia in Spanish patients. Acta Psychiatr Scand 114(6):435–438. doi:10.1111/j.1600-0447.2006.00874.x
169. Lawford BR, Young RM, Swagell CD, Barnes M, Burton SC, Ward WK, Heslop KR, Shadforth S, van Daal A, Morris CP (2005) The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia. Schizophr Res 73(1):31–37. doi:10.1016/j.schres.2004.08.020
170. Davis C, Levitan RD, Kaplan AS, Carter J, Reid C, Curtis C, Patte K, Hwang R, Kennedy JL (2008) Reward sensitivity and the D2 dopamine receptor gene: a case–control study of binge eating disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 32(3):620–628. doi:10.1016/j.pnpbp.2007.09.024
171. Nisoli E, Brunani A, Borgomainerio E, Tonello C, Dioni L, Briscini L, Redaelli G, Molinari E, Cavagnini F, Carruba MO (2007) D2 dopamine receptor (DRD2) gene Taq1A polymorphism and the eating-related psychological traits in eating disorders (anorexia nervosa and bulimia) and obesity. Eat Weight Disord EWD 12(2):91–96
172. Sery O, Drtilkova I, Theiner P, Pitelova R, Staif R, Znojil V, Lochman J, Didden W (2006) Polymorphism of DRD2 gene and ADHD. Neuro Endocrinol Lett 27(1–2):236–240
173. Klein TA, Neumann J, Reuter M, Hennig J, von Cramon DY, Ullsperger M (2007) Genetically determined differences in learning from errors. Science 318(5856):1642–1645. doi:10.1126/science.1145044
174. Hill SY, Zezza N, Wipprecht G, Locke J, Neiswanger K (1999) Personality traits and dopamine receptors (D2 and D4): linkage studies in families of alcoholics. Am J Med Genet 88(6):634–641
175. Ponce G, Jimenez-Arriero MA, Rubio G, Hoenicka J, Ampuero I, Ramos JA, Palomo T (2003) The A1 allele of the DRD2 gene (TaqI A polymorphisms) is associated with antisocial personality in a sample of alcohol-dependent patients. Eur Psychiatry J Assoc Eur Psychiatr 18(7):356–360
176. White MJ, Morris CP, Lawford BR, Young RM (2008) Behavioral phenotypes of impulsivity related to the ANKK1 gene are independent of an acute stressor. Behav Brain Funct BBF 4:54. doi:10.1186/1744-9081-4-54
177. Dan Eisenberg TA, MacKillop J, Modi M, Beauchemin J, Dang D, Lisman SA, Lum JK, Wilson DS (2007) Examining impulsivity as an endophenotype using a behavioral approach: a DRD2 TaqI A and DRD4 48-bp VNTR association study. Behav Brain Funct. doi:10.1186/1744-9081-3-2
178. Comings DE, Muhleman D, Gysin R (1996) Dopamine D2 receptor (DRD2) gene and susceptibility to posttraumatic stress disorder: a study and replication. Biol Psychiatry 40(5):368–372. doi:10.1016/0006-3223(95)00519-6
179. Comings DE, Wu S, Chiu C, Ring RH, Gade R, Ahn C, MacMurray JP, Dietz G, Muhleman D (1996) Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes—DRD2, D beta H, and DAT. Am J Med Genet 67(3):264–288. doi:10.1002/(SICI)1096-8628(19960531)67:3<264::AID-AJMG4>3.0.CO;2-N
180. Lee CC, Chou IC, Tsai CH, Wang TR, Li TC, Tsai FJ (2005) Dopamine receptor D2 gene polymorphisms are associated in Taiwanese children with Tourette syndrome. Pediatr Neurol 33(4):272–276. doi:10.1016/j.pediatrneurol.2005.05.005
181. Grevle L, Guzey C, Hadidi H, Brennersted R, Idle JR, Aasly J (2000) Allelic association between the DRD2 TaqI A polymorphism and Parkinson’s disease. Mov Disord Off J Mov Disord Soc 15(6):1070–1074
182. McGuire V, Van Den Eeden SK, Tanner CM, Kamel F, Umbach DM, Marder K, Mayeux R, Ritz B, Ross GW, Petrovitch H, Topol B, Popat RA, Costello S, Manthripragada AD, Southwick A, Myers RM, Nelson LM (2011) Association of DRD2 and DRD3 polymorphisms with Parkinson’s disease in a multiethnic consortium. J Neurol Sci 307(1–2):22–29. doi:10.1016/j.jns.2011.05.031
183. Schafer M, Rujescu D, Giegling I, Guntermann A, Erfurth A, Bondy B, Moller HJ (2001) Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene. Am J Psychiatry 158(5):802–804
184. Dubertret C, Gouya L, Hanoun N, Deybach JC, Ades J, Hamon M, Gorwood P (2004) The 3′ region of the DRD2 gene is involved in genetic susceptibility to schizophrenia. Schizophr Res 67(1):75–85
185. Perkins KA, Lerman C, Grottenthaler A, Ciccocioppo MM, Milanak M, Conklin CA, Bergen AW, Benowitz NL (2008) Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood. Behav Pharmacol 19(5–6):641–649. doi:10.1097/FBP.0b013e32830c367c
186. Ponce G, Hoenicka J, Jimenez-Arriero MA, Rodriguez-Jimenez R, Aragues M, Martin-Sune N, Huertas E, Palomo T (2008) DRD2 and ANKK1 genotype in alcohol-dependent patients with psychopathic traits: association and interaction study. Br J Psychiatry J Mental Sci 193(2):121–125. doi:10.1192/bjp.bp.107.041582
187. Fiorentini C, Guerra N, Facchetti M, Finardi A, Tiberio L, Schiaffonati L, Spano P, Missale C (2002) Nerve growth factor regulates dopamine D(2) receptor expression in prolactinoma cell lines via p75(NGFR)-mediated activation of nuclear factor-kappaB. Mol Endocrinol 16(2):353–366
188. Bontempi S, Fiorentini C, Busi C, Guerra N, Spano P, Missale C (2007) Identification and characterization of two nuclear factor-kappaB sites in the regulatory region of the dopamine D2 receptor. Endocrinology 148(5):2563–2570. doi:10.1210/en.2006-1618
189. Pohjalainen T, Nagren K, Syvalahti EK, Hietala J (1999) The dopamine D2 receptor 5′-flanking variant, −141C Ins/Del, is not associated with reduced dopamine D2 receptor density in vivo. Pharmacogenetics 9(4):505–509
190. Bertolino A, Fazio L, Caforio G, Blasi G, Rampino A, Romano R, Di Giorgio A, Taurisano P, Papp A, Pinsonneault J, Wang D, Nardini M, Popolizio T, Sadee W (2009) Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia. Brain J Neurol 132(Pt 2):417–425. doi:10.1093/brain/awn248
191. Duan J, Wainwright MS, Comeron JM, Saitou N, Sanders AR, Gelernter J, Gejman PV (2003) Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 12(3):205–216
192. Hirvonen M, Laakso A, Nagren K, Rinne JO, Pohjalainen T, Hietala J (2004) C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Mol Psychiatry 9(12):1060–1061. doi:10.1038/sj.mp.4001561
193. Hirvonen M, Laakso A, Någren K, Rinne JO, Pohjalainen T, Hietala J (2005) C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Mol Psychiatry 10:889
194. Hirvonen MM, Lumme V, Hirvonen J, Pesonen U, Nagren K, Vahlberg T, Scheinin H, Hietala J (2009) C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo. Prog Neuro-Psychopharmacol Biol Psychiatry 33(4):630–636. doi:10.1016/j.pnpbp.2009.02.021
195. Hirvonen M (2009) genetic factors in the regulation of striatal and extrastriatal dopamine D2 receptor expression. doria17-kklibhelsinkifi
196. Cravchik A, Sibley DR, Gejman PV (1996) Functional analysis of the human D2 dopamine receptor missense variants. J Biol Chem 271(42):26013–26017
197. Ritchie T, Noble EP (2003) Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem Res 28(1):73–82
198. Laruelle M, Gelernter J, Innis RB (1998) D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene. Mol Psychiatry 3(3):261–265
199. Finckh U, Rommelspacher H, Kuhn S, Dufeu P, Otto G, Heinz A, Dettling M, Giraldo-Velasquez M, Pelz J, Graf KJ, Harms H, Sander T, Schmidt LG, Rolfs A (1997) Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism. Pharmacogenetics 7(4):271–281
200. Lucht M, Samochowiec A, Samochowiec J, Jasiewicz A, Grabe HJ, Geissler I, Rimmbach C, Rosskopf D, Grzywacz A, Wysiecka JP, Tybura P, Brzuchalski B, Bienkowski P (2010) Influence of DRD2 and ANKK1 genotypes on apomorphine-induced growth hormone (GH) response in alcohol-dependent patients. Prog Neuro-Psychopharmacol Biol Psychiatry 34(1):45–49. doi:10.1016/j.pnpbp.2009.08.024
201. Laakso A, Pohjalainen T, Bergman J, Kajander J, Haaparanta M, Solin O, Syvalahti E, Hietala J (2005) The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects. Pharmacogenet Genomics 15(6):387–391
202. Hoenicka J, Quinones-Lombrana A, Espana-Serrano L, Alvira-Botero X, Kremer L, Perez-Gonzalez R, Rodriguez-Jimenez R, Jimenez-Arriero MA, Ponce G, Palomo T (2010) The ANKK1 gene associated with addictions is expressed in astroglial cells and upregulated by apomorphine. Biol Psychiatry 67(1):3–11. doi:10.1016/j.biopsych.2009.08.012
203. Garrido E, Palomo T, Ponce G, Garcia-Consuegra I, Jimenez-Arriero MA, Hoenicka J (2011) The ANKK1 protein associated with addictions has nuclear and cytoplasmic localization and shows a differential response of Ala239Thr to apomorphine. Neurotox Res 20(1):32–39. doi:10.1007/s12640-010-9219-6
204. Noble EP, Zhang X, Ritchie TL, Sparkes RS (2000) Haplotypes at the DRD2 locus and severe alcoholism. Am J Med Genet 96(5):622–631
205. Lawford BR, Young RM, Rowell JA, Gibson JN, Feeney GF, Ritchie TL, Syndulko K, Noble EP (1997) Association of the D2 dopamine receptor A1 allele with alcoholism: medical severity of alcoholism and type of controls. Biol Psychiatry 41(4):386–393. doi:10.1016/S0006-3223(96)00478-7
206. Neiswanger K, Kaplan BB, Hill SY (1995) What can the DRD2/alcoholism story teach us about association studies in psychiatric genetics? Am J Med Genet 60(4):272–275. doi:10.1002/ajmg.1320600403
207. Noble EP, Blum K (1993) Alcoholism and the D2 dopamine receptor gene. JAMA J Am Med Assoc 270(13):1547–1548
208. Munro CA, McCaul ME, Wong DF, Oswald LM, Zhou Y, Brasic J, Kuwabara H, Kumar A, Alexander M, Ye W, Wand GS (2006) Sex differences in striatal dopamine release in healthy adults. Biol Psychiatry 59(10):966–974. doi:10.1016/j.biopsych.2006.01.008
209. Dluzen DE, Anderson LI (1997) Estrogen differentially modulates nicotine-evoked dopamine release from the striatum of male and female rats. Neurosci Lett 230(2):140–142
210. Lerman C, Caporaso NE, Audrain J, Main D, Bowman ED, Lockshin B, Boyd NR, Shields PG (1999) Evidence suggesting the role of specific genetic factors in cigarette smoking. Psychol Off J Div Health Psychol Am Psychol Assoc 18(1):14–20
211. Carpenter MJ, Upadhyaya HP, LaRowe SD, Saladin ME, Brady KT (2006) Menstrual cycle phase effects on nicotine withdrawal and cigarette craving: a review. Nicotine Tob Res Off J Soc Res Nicotine Tob 8(5):627–638. doi:10.1080/14622200600910793
212. Finckh U, Giraldo-Velasquez M, Pelz J, Otto G, Sander T, Schmidt LG, Rommelspacher H, Rolfs A (1996) Dopamine D2 receptor gene (DRD2) haplotypes in Caucasians. Gene 179(2):251–255
213. Li TK (2000) Pharmacogenetics of responses to alcohol and genes that influence alcohol drinking. J Stud Alcohol 61(1):5–12
214. Wong AH, Buckle CE, Van Tol HH (2000) Polymorphisms in dopamine receptors: what do they tell us? Eur J Pharmacol 410(2–3):183–203